Biomarkers in endometriosis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031061

Enrollment

999

Registered

2023-01-23

Start date

2019-01-31

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Group 1: Patients diagnosed with endometriosis In this project, approx. 20 ml of blood will be collected twice (once preoperatively and once approx. 6-12 weeks postoperatively) and a representative ti

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Capacity to consent - All patients of the Department of Gynaecological Endocrinology and Fertility Disorders with planned laparoscopic surgical clarification to exclude (=control group)/to confirm endometriosis (study population) - Patients with laparoscopic clarification in the last 6 months with confirmed (study group) or excluded (control group) endometriosis (control group) endometriosis

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Detection of proteome/biomolecules	—

Secondary

Measure	Time frame
Influence of stages or subtypes of endometriosis (ovarian, deep infiltrating endometriosis etc.) on biomarkers	—

Countries

Germany

Contacts

Public ContactAriane Germeyer

Universitätsklinikum Heidelberg, Universitätsfrauenklinik Heidelberg

Ariane.Germeyer@med.uni-heidelberg.de+49-6221-567934

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026